Effects of glucagon-like peptide-1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across body mass index categories in type 2 diabetes: results of the LEADER and SUSTAIN 6 trials
| Image |  |
|---|---|
| Description | scientific article published on 03 August 2020 |
| Author/s |
author: Bernard Zinman Stephen Bain Subodh Verma Darren K McGuire |
| Publication date | August 3, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |